News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Samuel Z. Goldhaber, MD

Articles by Samuel Z. Goldhaber, MD

Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients

ByLisa J. McGarry, MPH,David Thompson, PhD,Milton C. Weinstein, PhD,Samuel Z. Goldhaber, MD

September 1st 2004

Latest Updated Articles

$Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients$
Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients
Published: September 1st 2004 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

5 Things to Know About the Oral GLP-1 Era

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text